Article Versions Notes

Libre C, Moro-Sibilot L, Giraud S, Martin L, Verhoeyen E, Costa C, Chebel A, Bissay N, Salles G, Genestier L, et al. Development of a Model for Chemical Screening Based on Collateral Sensitivity to Target BTK C481S Mutant. Cancers. 2020; 12(4):901. https://doi.org/10.3390/cancers12040901

Libre, Camille, Ludovic Moro-Sibilot, Stéphane Giraud, Laetitia Martin, Els Verhoeyen, Caroline Costa, Amel Chebel, Nathalie Bissay, Gilles Salles, Laurent Genestier, and et al. 2020. "Development of a Model for Chemical Screening Based on Collateral Sensitivity to Target BTK C481S Mutant" Cancers 12, no. 4: 901. https://doi.org/10.3390/cancers12040901

Libre, C., Moro-Sibilot, L., Giraud, S., Martin, L., Verhoeyen, E., Costa, C., Chebel, A., Bissay, N., Salles, G., Genestier, L., & Sujobert, P. (2020). Development of a Model for Chemical Screening Based on Collateral Sensitivity to Target BTK C481S Mutant. Cancers, 12(4), 901. https://doi.org/10.3390/cancers12040901